Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute.
Wassef
M
M
Vascular Biology Research Program, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-7956, USA. wassefm@nih.gov
Baxter
B T
BT
Chisholm
R L
RL
Dalman
R L
RL
Fillinger
M F
MF
Heinecke
J
J
Humphrey
J D
JD
Kuivaniemi
H
H
Parks
W C
WC
Pearce
W H
WH
Platsoucas
C D
CD
Sukhova
G K
GK
Thompson
R W
RW
Tilson
M D
MD
Zarins
C K
CK
D017544:Aortic Aneurysm, Abdominal / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism / Q000628:therapy; D001696:Biomechanical Phenomena; D015984:Causality; D003238:Connective Tissue / Q000502:physiology; D018450:Disease Progression; D004318:Doxycycline / Q000494:pharmacology / Q000627:therapeutic use; D018056:Hemorheology; D006801:Humans; D007249:Inflammation; D020780:Matrix Metalloproteinase 9 / Q000187:drug effects / Q000502:physiology; D008967:Molecular Biology; D009316:National Institutes of Health (U.S.); D020380:Needs Assessment; D009937:Organizational Objectives; D010348:Patient Care Team; D010447:Peptide Hydrolases / Q000502:physiology; D012106:Research / Q000458:organization & administration*; D012109:Research Support as Topic; D014481:United States
D010447:Peptide Hydrolases; D020780:Matrix Metalloproteinase 9; D004318:Doxycycline